The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, par
The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, par
Shuhong Chen, Yirui Ma, Peiyuan Huo, Yufeng Li et al.
Citations
1 citations
Journal
Travel Medicine and Infectious Disease
Topics
Rabies epidemiology and control
Field-Weighted Citation Impact (FWCI)
0.29
article
The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, par
Shuhong Chen, Yirui Ma, Peiyuan Huo, Yufeng Li, Meixia Wang, Qinghua Zhao, Jing Zhang, Lan Yu, Min Jia, Cha Wang, Wei Guang Zhao, Yin Yin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Travel Medicine and Infectious DiseaseVol. 63
Institutions
Capital Medical University (CN), Peking University (CN), Beijing Jishuitan Hospital (CN), Hebei Chemical and Pharmaceutical College (CN), Beijing YouAn Hospital (CN)